Agoracom Blog Home

Posts Tagged ‘Hemp’

« Older Entries
Newer Entries »

PRIMO Nutraceuticals Inc. $PROM.ca Harvests 13,000 lbs of Dried Bio-mass from Oregon Hemp Farm $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 8:24 AM on Wednesday, October 30th, 2019
  • Company has completed a harvest totaling 13,000 lbs of dried bio-mass of hemp from the Oregon hemp farm.
  • The dried bio-mass hemp is currently being stored at a local drying facility located near Eugene, Oregon.
  • The value for the crop in its current state is estimated to be worth $200,000 – $300,000 USD.

VANCOUVER, British Columbia, Oct. 30, 2019 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”)is pleased to announce that further to the Company news release dated October 1, 2019 the Company has completed a harvest totaling 13,000 lbs of dried bio-mass of hemp from the Oregon hemp farm. The dried bio-mass hemp is currently being stored at a local drying facility located near Eugene, Oregon. The value for the crop in its current state is estimated to be worth $200,000 – $300,000 USD. This will be added to the 28 kilo grams of crude oil currently in inventor from last year’s harvest. 

The completion of the 2019 harvest season is a major milestone for the company and for the hemp farm in Oregon, as this is the first year hemp has been federally legal since the Farm Bill was passed. This year in Oregon alone there are nearly 63,000 acres registered growing hemp compared to the 11,500 acres growing hemp registered in 2018. This is a significant increase in the amount of hemp being grown, which solidifies the Primo strategy of providing drying facilities to the ever growing hemp market in Oregon. Primo plans to have its first drying facility built and in operation by the end of the first quarter of next year.

President, Andy Jagpal Comments:

“I am very proud and excited with the amount of dried hemp that was harvested as it surpassed our expectations by a few thousand pounds. During a time in the cannabis market where companies have spent tens of millions of dollars building out facilities and cultivation infrastructure and have little to show for it, we have two harvests under our belt and product in inventory ready for sale. Together with this year’s harvest and last year’s inventory we estimate our inventory alone to be worth between $400,000 and $500,000 USD.”

VP Sales & Distribution, Andy Dhaliwal Comments:

“The on-hand inventory and quality of the hemp as starting material is a major advantage in the current marketplace. While the revenue opportunities from the harvest are extremely promising, the hemp processing infrastructure supports the expansion of our in-house product lines, and increases our white-label offering to the USA market as well. Both of which are tremendous assets for the company.”

About Primo Nutraceuticals, Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo provides fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. In addition to the Company’s flagship hemp project in Oregon State and the Greenhouse campus in Washington State, Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors
PRIMO NUTRACEUTICALS INC.

Andy Jagpal, President and Director

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/primo-nutraceuticals, as well as on the company’s site.

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816.

http://primoceuticals.com/
https://twitter.com/prmonutra
www.thriveCBD.org

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ddc63988-72ec-4630-a25d-5d418ba2ea1b

Tags: , , , , , ,
Posted in Bougainville Ventures, Featured, PRIMO Nutraceuticals Inc. | Comments Off on PRIMO Nutraceuticals Inc. $PROM.ca Harvests 13,000 lbs of Dried Bio-mass from Oregon Hemp Farm $CROP.ca $VP.ca NF.ca $MCOA

NORTHBUD $NBUD.ca – ‘It is quite amazing’: #CBD oil entering the mainstream $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:26 AM on Friday, October 18th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

‘It is quite amazing’: CBD oil entering the mainstream

By James Pugh

Some people are infusing the cannabis extract in cocktails, others are buying it in the form of dog treats, while many more are using it as a form of pain relief.

Unlike tetrahydrocannabinol, the psychoactive extract of the cannabis plant commonly known as THC, cannabidiol doesn’t cause users to get high.

And it is legal in the UK, assuming it does not contain one part in 10,000 of THC.

“When I first got involved with CBD I wanted to know what it was all about,” says Richard Butler, part of the management team at CBD Virtue, between Bridgnorth and Wolverhampton.

“It is still new in the UK.”

Some of the products

His company uses CBD to make products such as tablets, oils, body creams and balms.

Mr Butler says people are turning to CBD products to alleviate symptoms from physical ailments like pain and inflammation as well as mental ones like anxiety and depression.

At present, use of the oil is largely unregulated, and clinical trials into its usefulness are ongoing, but Mr Butler says he has witnessed its benefits.

“You learn more from the responses and feedback you get from customers,” he says. “It helps with pain relief, mental issues, anxieties.

“It also helps with eczema, psoriasis and acne – it is quite amazing actually.

“A lot of our initial customers were 40 plus and many were buying products for the younger generation.

Dean Burke using a CBD Pod Filler at CBD Virtue

“What has amazed me is the amount of depression and anxiety that exists among teenagers up to people in their late 20s.”

CBD oil, its proponents say, offers numerous benefits, from pain relief to reducing anxiety. As an anticonvulsant, it may also help treat neurological disorders such as epilepsy and multiple sclerosis.

CBD is also one of the biggest buzzwords in food and drink. It has been hailed the next big thing, with more and more chefs and producers using the products in their recipes.

After already taking other countries by storm, more businesses in the UK are looking to tap into the market.

Ross Burke viewing the product range at CBD Virtue

Mr Butler insists he has seen some significant success stories of people using the product for remedial purposes.

“I know someone who suffered with Parkinson’s for years who every time they woke up their whole body would be shaking and during the day they would shake out of control,” he says.

“I said ‘try this’ and within two weeks they went from their whole body shaking to feeling a slight twitch in their first finger and thumb.

“I am not allowed to say it cures cancer, but cancer sufferers are using it. There was someone who had skin cancer and it helped clear up blisters on their skin.

“My partner was on a lot of medication for various things and after taking four or five drops a day her stress and anxiety has gone.”

The product’s relationship to recreational cannabis also means that some people are reluctant to accept its use, and the medical benefits it provides have still to be proven beyond doubt.

But Mr Butler insists that the hemp-derived oil should be trusted.

“It is from a natural product that has been around for years,” he says. “Initially people were sceptical because it relates to cannabis. Yes, it is derived from cannabis plant, but the ‘high’ has been removed with the remedial side left behind.

The management team at CBD Virtue: Dean Burke, Richard Butler, Shannon Fyfe and Ross Burke

“We had the over 50s saying ‘ yeah but it’s cannabis, it’s cannabis’, but once you have explained to them they are willing to try it.

“A big part of my role has been educational. I would spend about two hours a day on Facebook educating people and answering a lot of questions.

“Initially it is getting people to try it, then after they see how effective it is they speak about it to their friends and family – a lot of it comes down to word of mouth.”

The plant is grown in Colorado in the USA, and a powdered form of the product is sent to the UK for the oil to be extracted by Richard’s team.

CBD Virtue employs 16 people, and is looking to double that by moving to larger premises to cope with demand.

Richard says: “We have a lab which is about 15ft by 20ft where a lot of our mixing is done. We also have another facility where we do the bottling up and everything else.

Jean Price packing up an order at CBD Virtue

“We are looking for larger premises due to growing demand and want to stay local. We employ 16 people and with the way things are going we are looking to double the workforce.”

Sales of products containing CBD have skyrocketed by 99 per cent in the UK, according to data.

Analysis by deals firm Wowcher suggests purchases of CBD products have almost doubled in 2019, with an increasing number of Brits trying the ingredient.

“The industry is exploding,” Mr Butler says. “Initially as a company we had a slow start with various issues with banks and online payment systems, but we have got more and more people on board who know how to get around these things.

Source: https://www.expressandstar.com/news/business/2019/10/17/it-is-quite-amazing-cbd-oil-entering-the-mainstream/

Tags: , , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – ‘It is quite amazing’: #CBD oil entering the mainstream $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Bougainville Ventures $BOG.ca – US retail sales of #CBD to increase 133% in 2019, surpass $10 billion by 2024 $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 5:41 PM on Thursday, October 17th, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

—————

US retail sales of CBD to increase 133% in 2019, surpass $10 billion by 2024

  • Retail sales of CBD in the U.S. are expected to surpass $1 billion in 2019 – a 133% increase over 2018 sales

DENVER, Oct. 17, 2019 — Retail sales of CBD in the U.S. are expected to surpass $1 billion in 2019 – a 133% increase over 2018 sales – and may eclipse $10 billion by 2024, according to projections from the newly released 2019 Hemp & CBD Industry Factbook, produced by the editors of Hemp Industry Daily.

The 2019 Hemp & CBD Industry Factbook predicts that retail sales of CBD in the U.S. are expected to surpass $1 billion in 2019 – a 133% increase over 2018 sales – and may eclipse $10 billion by 2024.

“The recent surge of consumer demand for CBD, coupled with increasingly easy access to CBD products, is expected to drive retail sales to about $1.1 billion-$1.3 billion in 2019,” said Kristen Nichols, editor of the 2nd Annual Hemp & CBD Industry Factbook. “We project retail CBD sales will increase to $10.3 billion by 2024, a five-year compound annual growth rate of 54%.”

When no federal agency tracks hemp as a commodity, the exclusively business focused 2019 Annual Hemp & CBD Industry Factbook provides understanding of the current and future challenges needed to make the most accurate and informed business decisions. Research-driven insights, will help business professionals understand economic, agricultural and regulatory developments impacting their positions and growth in the industry.

The 2019 Annual Hemp & CBD Industry Factbook offers:

  • 30+ charts exploring and analyzing the hemp & CBD market from critical angles including retail forecasts, consumer demand, production and more.
  • Top 10 hemp-producing state profiles exploring market conditions and retail trends.
  • Regulatory outlook, best practices, and future considerations for cultivators and processors looking to meet consumer demand
  • Benchmarks and wholesale prices, plus prices for hemp seeds and clone varietals
  • Pain points for growers and processors with a focus on input costs and per acre profits

“Imagine running a race with brand-new shoes and a burst of energy but no idea what the course looks like. That’s somewhat the position in which today’s hemp industry finds itself,” said Nichols. “Relying on deeply researched data points along the way could make the difference between hitting the finish line and running off course.”

Source: https://www.prnewswire.com/news-releases/us-retail-sales-of-cbd-to-increase-133-in-2019-surpass-10-billion-by-2024-300940056.html

Tags: , , , , , , ,
Posted in Bougainville Ventures | Comments Off on Bougainville Ventures $BOG.ca – US retail sales of #CBD to increase 133% in 2019, surpass $10 billion by 2024 $CROP.ca $VP.ca NF.ca $MCOA

North Bud Farms $NBUD.ca Announces the Appointment of Sean Homuth as Acting Chief Financial Officer $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:03 AM on Thursday, October 17th, 2019
  • Announce the appointment of Sean Homuth as Acting Chief Financial Officer, effective today
  • Mr. Homuth’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company

TORONTO, Oct. 17, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) is pleased to announce the appointment of Sean Homuth as Acting Chief Financial Officer (CFO), effective today. Mr. Homuth’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company. 

“As NORTHBUD expands its presence into the USA with the anticipated closing of its previously announced letters of intent with the Qlora Group (California) and Nevada Botanical Science (Nevada), we are strategically adding additional expertise in international business and finance,” said Ryan Brown, CEO of North Bud Farms Inc.

Mr. Homuth brings extensive experience with both Canadian and U.S. publicly traded organizations both in industry as well as from a client perspective during his tenure at Ernst & Young and, more recently, as an independent consultant. Previously, Mr. Homuth was Chief Financial Officer at Orezone Gold Corporation (and Vice President, Finance and Administration for its predecessor company, Orezone Resources Inc.) a publicly listed company headquartered in Canada with operations in West Africa. At Orezone Mr. Homuth led a global team of finance professionals and was involved in over $800 million in financings and M&A transactions with the company and its predecessor. Mr. Homuth holds accounting designations in both Canada (CPA, CA) and the United States (CPA – Illinois).

“We are pleased to welcome Sean to our dynamic team as NORTHBUD expands its footprint into the USA,” stated Ryan Brown, CEO of North Bud Farms Inc. “Sean brings specialty experience in accounting and finance for international companies as well as a profound knowledge of capital markets, having worked with and advised many public companies over the years. He joins NORTHBUD at an exciting time in its development as his leadership and experience will be essential in executing our strategic plan and taking the company to its next level of growth.”

Brendan Stutt, the Company’s incumbent CFO, who has made invaluable contributions to the Company’s financial leadership and culture, will work to ensure a smooth transition and will remain with the Company in a non-executive role.

Mr. Brown stated: “We would like to thank Brendan for his contributions to the Company, in particular the successful listing of NORTHBUD on the Canadian Securities Exchange.” 

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act. The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has entered into agreements to acquire assets in California and Nevada.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. This press release contains forward- looking statements including those relating to the entering into of the Definitive Agreement and closing of the Transaction with the Qlora Group and Nevada Botanical Science. Forward-looking statements are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Tags: , , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Announces the Appointment of Sean Homuth as Acting Chief Financial Officer $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Bougainville Ventures $BOG.ca – CBD Demand Soars With a Growing Number of Uses $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 1:27 PM on Tuesday, October 15th, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

CBD Demand Soars With a Growing Number of Uses

  • Global cannabidiol market is expected to grow from USD 1.04 Billion in 2018 to USD 16.32 Billion by 2026 while registering a CAGR of 27.7% during the forecast period, according to data compiled by Reports and Data

NEW YORK, Oct. 15, 2019 – As the medical industry continues to evolve, researchers are actively looking for innovative remedies and treatments for patients. Notably, cannabis has become the topic of discussion after numerous researchers and institutions highlighted its therapeutic benefits. However, despite medical advancements throughout the cannabis industry, most federal regulators around the world have not yet moved to fully legalize cannabis for medical applications because of the psychotropic effects associated with it. Nevertheless, several regulators have decided to legalize cannabidiol, or CBD, a compound found within cannabis. CBD is a derivative found within the cannabis plant, however, unlike its tetrahydrocannabinol, or THC, counterpart, it does not induce psychoactive effects. Consequently, regulators became more inclined to legalize CBD. Primarily, the CBD industry is being accelerated by the healthcare segment.

Specifically, countries such as Australia, Canada, France, Germany, Italy, the U.K. and the U.S. have all adopted CBD-related legislation. Overall, the therapeutic grade segment dominates that overall CBD market because of increasing demand from innumerable applications. The segment accounted for 58.6% of the overall CBD market share and is expected to continue its dominance. In particular, the healthcare segment is expected to account for a total of USD 10.28 Billion of the CBD market by 2026. Moreover, the food and beverage industry is also expected to witness exponential growth. And while the U.S. and Canada are the primary drivers for the global CBD market, other international markets are also expected to greatly contribute. For instance, the Asia Pacific market is anticipated to reach USD 3.1 Billion by 2026 and exhibit a CAGR of 29.5%, while the European market is projected to grow at a CAGR of 28.9%. As a result, the global cannabidiol market is expected to grow from USD 1.04 Billion in 2018 to USD 16.32 Billion by 2026 while registering a CAGR of 27.7% during the forecast period, according to data compiled by Reports and Data.

The pharmaceutical segment of the CBD industry is expected to witness significant R&D investments to accelerate deployment and meet the medical needs of a number of diseases. Specifically, researchers have uncovered that CBD can treat a variety of diseases such as chronic pain, anxiety, depression, and cancer. And while most of these conditions would likely require a prescription from a medical practitioner, there are over-the-counter or OTC products that consumers can easily purchase at their local convenience stores in the U.S. or Canada. Consumers can purchase CBD-based products such as tinctures, topicals, patches, capsules, foods, and beverages. Typically, most OTC products are marketed as health and wellness products that are aimed to relieve minor ailments. For instance, many health and wellness retailers promote CBD as a way to stimulate relaxation or relieve small headaches. Notably, major pharmaceutical retailers such as CVS or Walgreens have also decided to add CBD products to their shelves. The two corporations added CBD products in order to provide consumers with cheaper and alternative care products. “It really does help normalize this. If Grandma can go to the store and get it, now the conversation about cannabis is going to be very different,” said Michele Ross, PhD, MBA, Research Director at Decriminalize California. “CBD business is already huge. But normalizing the culture around taking these products is going to open the door for more people to feel comfortable investing in these types of businesses. It opens up the possibility for them to be sold in more stores.”

Source: https://www.prnewswire.co.uk/news-releases/cbd-demand-soars-with-a-growing-number-of-uses-815946592.html

Tags: , , , , , , ,
Posted in Bougainville Ventures | Comments Off on Bougainville Ventures $BOG.ca – CBD Demand Soars With a Growing Number of Uses $CROP.ca $VP.ca NF.ca $MCOA

The Miracle That Is #CBD, Might Help Breast Cancer Patients Too – SPONSOR: Empower Clinics $CBDT $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 12:08 PM on Friday, October 11th, 2019

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics
  • Patient database of over 165,000 patients 
  • Platform generating $4MM USD in revenue annually (2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Launching CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025

The Miracle That Is CBD, Might Help Breast Cancer Patients Too

By: Erika W. Smith  

CBD is in our lattes, moisturizers, and chocolates, but what about its use in a hospital setting instead of your local café or beauty store? Although more study is needed, research suggests that CBD may have the potential to help relieve certain side effects of chemotherapy.  

CBD is short for cannabidiol, which is one of the many compounds found in cannabis and hemp. Unlike tetrahydrocannabinol (THC), it’s non-psychoactive. Manufacturers have found a way to separate CBD from the plants, and the Agriculture Improvement Act of 2018 (aka the Farm Bill) legalized hemp-derived CBD that contains no more than 0.3% THC and is made from hemp grown by licensed producers. (That’s why you’ve seen so many CBD products recently.) But so far, the Food and Drug Administration has only approved one form of CBD: Epidiolex, a drug containing a purified marijuana-derived form of CBD, which is used for preventing seizures caused by rare forms of epilepsy. 

However, medical marijuana — which contains CBD as well as THC and other compounds — has been used by cancer patients for many years. In 1996, California became the first state to legalize marijuana for medical use. And although marijuana is still illegal on a federal level, it’s currently legal for medical use in 33 states — and it’s approved for use by cancer patients in every state in which medical marijuana is legal. (For comparison, medical marijuana is approved for use by patients with Crohn’s disease in only 27 states.) Additionally, the FDA has approved two chemically pure drugs based on marijuana compounds to treat nausea and vomiting in cancer chemotherapy patients.   

A 2016 review of medical marijuana’s use in oncology, published by the American Medical Association journal JAMA Oncology, notes, “Marijuana in oncology may have potential for use as an antiemetic [relieving nausea and vomiting], for refractory cancer pain, and as an antitumor agent. However, much of the data are based on animal data, small trials, or are outdated.” The authors concluded that more research is needed into medical marijuana’s therapeutic use for cancer patients.  

There is even less research into CBD’s potential benefits for cancer patients. But still, some studies have been conducted. According to the National Cancer Institute, research indicates that CBD may slow the growth or reduce the risk of recurrence of certain kinds of cancers, including breast cancer; enhance the potency of certain medications; and reduce chemotherapy side effects including vomiting, nausea, and anxiety. However, all these studies are limited, and experts agree that further research is needed to understand just how CBD affects humans.  

Source: https://www.refinery29.com/en-us/cbd-oil-breast-cancer

Tags: , , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on The Miracle That Is #CBD, Might Help Breast Cancer Patients Too – SPONSOR: Empower Clinics $CBDT $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Empower Clinics $CBDT.ca Provides Corporate Updates Highlighting Triple Digit Patient Growth and Subsidiary Sun Valley Health Launches New Modalities and Patient Services $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:43 AM on Thursday, October 10th, 2019
  • Patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 versus September 2018 with 614 patients seen
  • Launching seven new modalities and services for patients in the Sun Valley Health clinics

VANCOUVER, Oct. 10, 2019  – EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, a multi-state operator of medical health & wellness clinics, a CBD product producer and operator of an extraction facility in Oregon, is pleased to announce it is launching seven new modalities and services for patients in the Sun Valley Health clinics commencing Monday October 14th, 2019.

The Company also has patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 versus September 2018 with 614 patients seen.

“The tremendous year-over-year increase in patient visits is a testament to the operating strengths and patient management demonstrated by our clinic team members, each and every day,” said Steven McAuley, CEO of Empower. “Their passion for patient wellbeing and the use of numerous communication tools ensures world-class service is provided throughout the entire patient journey.”

As part of the Company’s continued expansion of our health & wellness clinic model, we have already set up retail CBD product sales in-clinic, and now we have launched expanded physician based services.

New Modalities and Services

  • Physician’s CBD Enhanced Massage, Acupuncture, or Cupping Sessions
  • CBD-Cannabis-Supplement Consumption & Coaching Consultation
  • Introduction to Alternative Health and Cannabinoid Therapies by a Physician
  • Comprehensive Naturopathic Patient Analysis & Consultation
  • Dietary Antigen Testing, Physician Consultation/Action Plan, & Concierge Blood Draw
  • Neurotransmitter (urine) Profile & Physician Consultation/Action Plan
  • Spectracell Micronutrient Test & Physician Consultation/Action Plan

“By offering our new suite of laboratory testing, alternative health consulting, and CBD therapies we are able to address the needs of our current patients and serve the community outside of cannabis that are seeking alternative health care,” states Dustin Klein, Director & VP Business Development. “Incorporating our new modalities, high quality vitamins, supplements, and CBD products into our network of clinics is a natural progression toward our goal of becoming the nation’s premier alternative healthcare provider.”

Additional UPDATES

  • New Modalities and Patient Services The Company continues to see patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 over July 2018 614 patients seen.

  • Sun Valley Health Franchise Sun Valley Health www.sunvalleyhealth.com has been actively participating in various franchise and cannabis expos in St. Louis, Chicago and Houston to market the Sun Valley Health franchise program, attracting numerous qualified candidates for available territory locations. The Company has accepted many applications and has provided the Franchise Disclosure Document (FDD) to qualified applicants in anticipation of completing the first initial territory sales.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , , , ,
Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Provides Corporate Updates Highlighting Triple Digit Patient Growth and Subsidiary Sun Valley Health Launches New Modalities and Patient Services $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

PODCAST: Why #cannabis 3.0 is the real opportunity for Canada with Bruce Linton – SPONSOR: #NORTHBUD $NBUD.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 12:55 PM on Wednesday, October 9th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

PODCAST: Why ‘cannabis 3.0’ is the real opportunity for Canada with Bruce Linton

By: Emily Jackson

Welcome to Down to Business, a weekly podcast from the Financial Post.

It’s been one year since Canada legalized the recreational cannabis industry after a century of prohibition. But it’s just the beginning of the journey from the black market to “cannabis 3.0.”

In the lead-up to the election, Down to Business has focused on business issues with a political twist. This week, host Emily Jackson discusses the cannabis industry’s one-year legalization anniversary with Bruce Linton, the former chief executive of Canopy Growth, Canada’s largest cannabis company.

Linton discusses lessons from the first round of legalization for recreational use, what to expect from the impending introduction of cannabis infused beverages and edibles, and why Canada needs to focus on “cannabis 3.0” if it wants to be a global leader.

You can listen below — or on Apple Podcasts, Spotify, Stitcher and Google Play, where you can also subscribe to get new episodes every Wednesday morning.

Source: https://business.financialpost.com/cannabis/cannabis-business/down-to-business-podcast-why-cannabis-3-0-is-the-real-opportunity-for-canada

Tags: , , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on PODCAST: Why #cannabis 3.0 is the real opportunity for Canada with Bruce Linton – SPONSOR: #NORTHBUD $NBUD.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Bougainville Ventures Inc. Appoints Mr. Andy Dhaliwal, President of Thrive Nutrition to Vice President of Sales and Distribution $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:54 AM on Tuesday, October 8th, 2019
  • Company has appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice President of Sales and Distribution for Bougainville Ventures Inc. 

VANCOUVER, British Columbia, Oct. 08, 2019 — BOUGAINVILLE VENTURES INC. (CSE: BOG) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that further to the signing of the definitive agreement to complete the acquisition of Thrive Nutrition Products Ltd. (“Thrive Wellness”) announced in the Company news release dated September 24, 2019, the Company has appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice President of Sales and Distribution for Bougainville Ventures Inc.  Thrive Wellness is a preeminent distributor of hemp & cannabinoid-focused natural health products under the “THRIVE WELLNESS” brand.

About Thrive Nutrition Products Ltd.
Thrive Wellness is a distributor of premium hemp and natural health products with operations currently in Canada and the USA. Thrive specializes in the development, marketing and distribution of cannabinoid products refined into their own natural health product brand. The company was founded in Vancouver, British Columbia and is the first of its kind with national retail distribution in Canada. Thrive has achieved $2,500,000 CDN in sales through retail distribution, its’ e-commerce website and their relationship with Nutrition House, Canada’s leading Natural Health Product franchise. Founded in 1979 the company began franchising in 1993 and now operates over 45 retail stores, located in high profile shopping centers across Canada, and in the USA. www.nutritionhouse.com

CEO, Andy Dhaliwal Comments:

“I am very excited to be a joining a team that is extremely well positioned for significant growth in the emerging cannabis & hemp markets. I look forward to helping Bougainville continue building shareholder value and to increase our international exposure through this partnership. I am particularly keen on the CBD opportunity in the U.S., where Bougainville already has resources available.”

Mr. Dhaliwal is a pioneering expert in the marketing of cannabis, hemp, and natural health products, and brings over 12 years of experience in the industry. In addition to serving as the CEO of Thrive Wellness, he was an advisor for the Province of British Columbia’s Cannabis Operations, where he advised on corporate development and sales optimization. 

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/bog-news, as well as on the company’s site.

About the CBD Market

Bank of America projects a spend of $1.3 Billion on CBD in Canada by 2022, while $1.9 Billion is being spent in the USA currently, and another $4.4 Billion in Europe this year. Demand for CBD and Hemp is increasing year over year, with Merrill Lynch predicting an $11.5 Billion American market by 2032.

About Bougainville Ventures, Inc.

Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington State, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.

Andy Jagpal, President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816

http://bougainvilleinc.com/https://twitter.com/bougainvilleincwww.thriveCBD.org

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Tags: , , , , , ,
Posted in Bougainville Ventures | Comments Off on Bougainville Ventures Inc. Appoints Mr. Andy Dhaliwal, President of Thrive Nutrition to Vice President of Sales and Distribution $CROP.ca $VP.ca NF.ca $MCOA

Another First for the #Pot Industry: A Licensed Cannabis Restaurant SPONSOR: NORTHBUD $NBUD.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:01 AM on Monday, October 7th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

Another First for the Pot Industry: A Licensed Cannabis Restaurant

  • Cannabis edibles are a growing segment of the market and are expected to reach $4.1 billion in 2022, combining Canadian and U.S. sales.
  • In 2017, that figure was just $1 billion among the two countries. The segment is going to be key to the industry’s long-term growth.

By: David Jagielski

Cannabis edibles are a growing segment of the market and are expected to reach $4.1 billion in 2022, combining Canadian and U.S. sales. In 2017, that figure was just $1 billion among the two countries. The segment is going to be key to the industry’s long-term growth.

Restaurants haven’t been able to take advantage of that growth since the U.S. Food and Drug Administration has still not permitted cannabidiol (CBD) to be infused into food. While the FDA has held hearings on CBD, there’s no indication that changes are coming anytime soon.

One restaurant, however, has been able to get around that problem. Lowell Farms opened its doors earlier this month in West Hollywood, Calf., and it’s the first restaurant with a lounge licensed for cannabis use. Customers will be able to eat food and consume pot at the same establishment. That doesn’t mean the restaurant will be able to make and serve cannabis food. Instead, cannabis edibles will be permitted only if they are “produced by an outside source.” 

One of the other restrictions the restaurant will face is not being able to sell alcohol to diners. It’s a small price to pay to let them consume cannabis, since pot lounges remain a rarity in the industry. Las Vegas is among the cities looking at permitting such lounges, but that could be years away because there’s still a lot of opposition to it. 

Will a bar someday be a place to enjoy pot with friends? Image source: Getty Images.

Why lounges could be big for the industry

While marijuana has been legalized in many parts of the U.S., that doesn’t mean it’s possible to consume it at bars or sporting events, unlike alcohol where there are many places that users can drink in a social setting. Allowing that could unlock another avenue of growth for the industry.

Cannabis beverages are on the rise and expected to grow globally at a rate of more than 15% per year from now until 2025, reaching $4.5 billion in market size by then. So there’s going to be a growing need for places to enjoy such drinks with friends without always having to do so at home. And that doesn’t even factor in the growth of edibles that could be consumed at lounges, such as candy, cookies, and chocolate.

In Canada, there’s potential for Canopy Growth to test its products in one lounge that was made legal earlier this year. In many ways, the emerging Canadian cannabis edibles market, which is going to be legalized later this month and where the first products will be available in December , could prove to be a good indicator of how successful some of these concepts will be in the U.S. And for Canopy Growth, it could be an important way to get closer to breakeven.

For now, Canopy Growth can be a good opportunity for investors to take advantage of the new edibles market in Canada. Not only is the company well-positioned for success in the beverages segment, but in a recent interview with BNN Bloomberg, CEO Mark Zekulin said the company was working on more than 50 different products for the edibles market. That could lead to significant growth for Canopy Growth and get investors excited about the stock once again.

Here’s The Marijuana Stock You’ve Been Waiting For

A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming.

Cannabis legalization is sweeping over North America – 10 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018.

And one under-the-radar Canadian company is poised to explode from this coming marijuana revolution.

Because a game-changing deal just went down between the Ontario government and this powerhouse company…and you need to hear this story today if you have even considered investing in pot stocks.

Source: https://www.fool.com/investing/2019/10/06/another-first-for-the-cannabis-industry-a-licensed.aspx

Tags: , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on Another First for the #Pot Industry: A Licensed Cannabis Restaurant SPONSOR: NORTHBUD $NBUD.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

« Older Entries
Newer Entries »